Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.
Yunha NamHo Cheol KimYoung-Chul KimSeung Hun JangKye Young LeeShin-Yup LeeSang Hoon LeeSung Yong LeeSeong Hoon YoonJeong-Seon RyuTae Won JangYoon Soo ChangSeung Joon KimChan Kwon ParkJeong Eun LeeChi Young JungChang-Min ChoiPublished in: Thoracic cancer (2021)
Rebiopsy might affect the clinical course of patients with EGFR-mutant adenocarcinoma who receive EGFR-TKIs.